SCHEMBL14021270

SCHEMBL14021270

COCCCN1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(Cl)cc4)n3)cc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 3/20 0.54
▸ IKBKB O14920 1/20 0.53
▸ CHUK O15111 1/20 0.53
▸ IKBKG Q9Y6K9 1/20 0.53
▸ AIMP2 Q13155 1/20 0.52
▸ PIK3CA P42336 2/20 0.51
▸ PIK3CB P42338 2/20 0.51
▸ PIK3CG P48736 2/20 0.51
▸ JAK2 O60674 6/20 0.49
▸ JAK3 P52333 4/20 0.49
▸ SYK P43405 2/20 0.49
▸ JAK1 P23458 1/20 0.48
▸ KCNA5 P22460 2/20 0.48
▸ DRD3 P35462 1/20 0.48
▸ CDK1 P06493 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ MAPKAPK2 P49137 1/20 0.47
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3056212 0.90 AIMP2 (0.54) DRD2IKBKBCHUKAIMP2PIK3CA
SCHEMBL14021310 0.89 SYK (0.53) IKBKBCHUKIKBKGAIMP2PIK3CA
SCHEMBL14021629 0.89 JAK2 (0.54) IKBKBCHUKIKBKGAIMP2PIK3CA
SCHEMBL14021298 0.88 SYK (0.52) DRD2IKBKBCHUKIKBKGAIMP2
SCHEMBL14021295 0.88 AIMP2 (0.52) DRD2IKBKBCHUKAIMP2PIK3CA
SCHEMBL13590773 0.88 PIK3CA (0.47) DRD2IKBKBCHUKIKBKGAIMP2
SCHEMBL3049760 0.87 SYK (0.51) IKBKBCHUKIKBKGAIMP2PIK3CA
SCHEMBL14021308 0.87 JAK2 (0.55) JAK2JAK3SYKJAK1CDK2
SCHEMBL8311018 0.86 JAK2 (0.61) IKBKBCHUKIKBKGAIMP2PIK3CA
SCHEMBL14021306 0.86 SYK (0.54) IKBKBCHUKIKBKGAIMP2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
Send feedback